Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Modelling alternative strategies for delivering hepatitis B vaccine in prisons : the impact on the vaccination coverage of the injecting drug user population

Tools
- Tools
+ Tools

Sutton, A. J., Gay, N. J., Edmunds, W. John and Gill, O. N.. (2008) Modelling alternative strategies for delivering hepatitis B vaccine in prisons : the impact on the vaccination coverage of the injecting drug user population. Epidemiology and Infection, Vol.136 (No.12). pp. 1644-1649. ISSN 0950-2688

[img] PDF
WRAP_sutton_Hepititus_B_vaccine_prison.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Download (153Kb)
Official URL: http://dx.doi.org/10.1017/S0950268808000502

Abstract

Since 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited periods, suggesting that short campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the flow of prisoners through prisons stratified by injecting status to compare a range of vaccination scenarios that describe vaccination on prison reception or via regular short campaigns. Model results suggest that vaccinating on prison reception can capture a greater proportion of the injecting drug user (IDU) population than the comparable campaign scenarios (63% vs. 55 . 6% respectively). Vaccination on prison reception is also more efficient at capturing IDUs for vaccination than vaccination via a campaign, although vaccination via campaigns may have a role with some infections for overall control.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine
Divisions: Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH): Hepatitis B -- Vaccination, Prisoners -- Health and hygiene, Drug abuse, Prisons -- Mathematical models
Journal or Publication Title: Epidemiology and Infection
Publisher: Cambridge University Press
ISSN: 0950-2688
Date: 2008
Volume: Vol.136
Number: No.12
Page Range: pp. 1644-1649
Identification Number: 10.1017/S0950268808000502
Status: Peer Reviewed
Access rights to Published version: Open Access
Funder: Great Britain. Dept. of Health (DoH)
References: 1. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and UASSG. Shooting up; infections among injecting drug users in the United Kingdom 2004: an update, October 2005. London: Health Protection Agency, 2005. 2. Health Protection Agency (www.hpa.org.uk). Accessed December 2006. 3. Weild AR, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a National Survey. Communicable Disease and Public Health 2000; 3: 121–126. 4. Sutton AJ, et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection 2006; 134: 231–242. 5. Gore SM, et al. Anonymous HIV surveillance with risk-factor elicitation : at Perth (for men) and Cornton Vale (for women) prisons in Scotland. International Journal of STD & AIDS 1997; 3: 166–175. 6. Allwright S, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners : results of a national cross sectional survey. British Medical Journal 2000; 321: 78–82. 7. Vong S, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis a outbreak among methamphetamine drug users. Vaccine 2005; 23: 1021–1028. 8. Gilbert RL, et al. Hepatitis A vaccination – a prisonbased solution for a community-based outbreak? Communicable Disease and Public Health 2004; 7: 289–293. 9. Gilbert RL, et al. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Communicable Disease and Public Health 2004; 7: 306–311. 10. Hutchinson SJ, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004; 23: 210–214. 11. Sutton AJ, Gay NJ, Edmunds WJ. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine 2006; 24: 2377–2386. 12. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS 2005; 19 (Suppl. 3) : S41–S46. 13. Bird AG, et al. Anonymous HIV surveillance with risk factor elicitation at Scotland’s largest prison, Barlinnie. AIDS 1995; 9: 801–808. 14. Sutton AJ, et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infectious Diseases 2006; 6: 93.
URI: http://wrap.warwick.ac.uk/id/eprint/3199

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us